N-(2,3-dichlorobenzyl)cyclopropanamine hydrochloride, 98%, 1g

(S)-METHYL 2-AMINO-2-CYCLOPENTYLACETATE, 95.0%, 250mg

4-Quinazolinamine, 6,7-dimethoxy-N-phenyl-, 97%, 250mg

6-Bromo-4-chloro-3-iodo-1H-indazole, 95%, 100mg

tert-Butyl (3-(2-hydroxyethyl)bicyclo[1.1.1]pentan-1-yl)carbamate, 98%, 250mg

Benzyl 3-oxo-8-azabicyclo[3.2.1]octane-8-carboxylate, 95.0%, 25g

Cyclothiazide (mixture of isomers)>95.0%(HPLC)100mg

3-(4-Chlorobenzenesulfonylamino)propionic acid, 95.0%, 1g

Tiglic Acid>98.0%(GC)(T)100g

5-(aminomethyl)-1-methyl-1,2-dihydropyridin-2-one hydrochloride, 97.0%, 1g

Surveillance des fuites Modèle II

tert-Butyl ((2S,3R)-3-hydroxy-4-(isobutylamino)-1-phenylbutan-2-yl)carbamate, 95.0%, 5g

Z-Arg(NO2)-OH, 95%, 1g